+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Radiotheranostics Market Size, Share & Trends Analysis Report By Radioisotope (Iodine-131, Iodine-123, Gallium-68, Lutetium-177, 18F with Y-90), By Approach, By Application (Oncology, Non-oncology), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • May 2023
  • Region: Global
  • Grand View Research
  • ID: 5830901
Description Jump to:
The global radiotheranostics market size is expected to reach USD 20.69 billion by 2030. The market is expected to expand at a CAGR of 13.49% from 2023 to 2030. The increasing incidence of cancer coupled with an increasing adoption of injectable radiopharmaceuticals with antitumor effects is the major factor driving the global radiotheranostics market. Radiotheranostics have paved the way for novel cancer diagnostics and treatment approaches as these agents are becoming increasingly popular among healthcare professionals owing to various benefits of these agents.

Radiotheranostics is becoming increasingly important in diagnosis and treatment of wide range of diseases including cancer. Advancements in screening technology for efficient disease diagnosis, widespread application of existing products, and rising approvals of novel radiotheranostic agents are further accelerating the industry expansion. For instance, approval of agents like Lu-PSMA-617, Lu-DOTATAT have facilitated the interest in this field.

Injectable radiopharmaceuticals with antitumor effects have witnessed a rapid development in the recent years. Most of the products are already approved for human use and the more radiotheranostics are under development phase, potentially introducing novel therapeutic choices for the patients. The rising efforts from market players to develop newer route of administrations for radiotheranostic products to reduce toxicity instances is likely to cater market growth. For instance, most of these products are given by IV route, but sometimes it might present some challenge in delivering right amount of dose in patients with localized disease. Hence to overcome this the market players are developing catheter-delivered intra-arterial radiotheranostics.

Moreover, increased inclination towards precision medicine and nuclear medicine, and presence of favorable reimbursement framework for nuclear medicine diagnostics is creating momentum for the industry. For instance, majority of health insurance programs of U.S. and Centers for Medicare & Medicaid Services cover all PET through NCD which include tracers important for diagnosis of solid tumors. In addition, CMS has given certain reimbursement guidelines for radiopharmaceuticals including Tc labeled products, Iodine labeled products, and miscellaneous products.

Radiotheranostics Market Report Highlights

  • The lutetium-177 segment held the largest share of 40.91% in 2022 owing to the increasing prevalence of cancer and high availability of Lu177 based products
  • The targeted therapeutic segment accounted for the fastest growth rate over the forecast period due to factors such as presence of robust investigation pipeline coupled with rising significance of radiotheranostics in cancer treatment.
  • Based on application, the oncology segment dominated the market in 2022, whereas non-oncology application is projected to be the fastest-growing segment.
  • Asia Pacific is projected to exhibit the fastest growth over the forecast period due to large patient pool and increasing investment in nuclear medicine space.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Competitive Insights
Chapter 3 Radiotheranostics Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market
3.2 Market Dynamics
3.2.1 Market drivers analysis
3.2.1.1 Increasing prevalence of cancer
3.2.1.2 Growing use of radiotheranostics in cancer diagnosis and management
3.2.1.3 Rising trend of nuclear medicine
3.2.2 Market restraint analysis
3.2.2.1 Requirement of higher cost for radiotheranostics development
3.2.2.2 Short shelf life of theranostic agents
3.3 Radiotheranostics: Market Analysis Tools
3.3.1 Industry analysis - Porter’s
3.3.2 PESTLE analysis
3.4 Regulatory Framework
Chapter 4 Radiotheranostics Market Segment Analysis, By Radioisotope, 2018 - 2030 (USD Million)
4.1 Definition and Scope
4.2 Radioisotope Market Share Analysis, 2022 & 2030
4.3 Segment Dashboard
4.4 Global Radiotheranostics Market, by Radioisotope, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5.1 Iodine-131
4.5.1.1 Iodine-131 market estimates and forecast, 2018 - 2030 (USD Million)
4.5.2 Iodine-123
4.5.2.1 Iodine-123 market estimates and forecast, 2018 - 2030 (USD Million)
4.5.3 Gallium-68
4.5.3.1 Gallium-68 market estimates and forecast, 2018 - 2030 (USD Million)
4.5.4 Lutetium-177
4.5.4.1 Lutetium-177 market estimates and forecast, 2018 - 2030 (USD Million)
4.5.5 18F with Y-90
4.5.5.1 18F with Y-90 market estimates and forecast, 2018 - 2030 (USD Million)
4.5.6 Others
4.5.6.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5 Radiotheranostics Market Segment Analysis, By Approach 2018 - 2030 (USD Million)
5.1 Definition and Scope
5.2 Approach Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 Global Radiotheranostics Market, by Approach, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.5.1 Targeted Therapeutic
5.5.1.1 Targeted therapeutic market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2 Targeted Diagnostic
5.5.2.1 Targeted diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6 Radiotheranostics Market Segment Analysis, By Application, 2018 - 2030 (USD Million)
6.1 Definition and Scope
6.2 Application Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 Global Radiotheranostics Market, by Application, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Oncology
6.5.1.1 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
6.5.1.2 Thyroid Cancer
6.5.1.2.1 Thyroid cancer market estimates and forecast, 2018 - 2030 (USD Million)
6.5.1.3 Neuroendocrine Tumors
6.5.1.3.1 Neuroendocrine tumors market estimates and forecast, 2018 - 2030 (USD Million)
6.5.1.4 Hepatocellular Carcinoma
6.5.1.4.1 Hepatocellular carcinoma market estimates and forecast, 2018 - 2030 (USD Million)
6.5.1.5 Prostate Cancer
6.5.1.5.1 Prostate cancer market estimates and forecast, 2018 - 2030 (USD Million)
6.5.1.6 Others
6.5.1.6.1 Others cancer market estimates and forecast, 2018 - 2030 (USD Million)
6.5.2 Non-oncology
6.5.2.1 Non-oncology market estimates and forecast, 2018 - 2030 (USD Million)
6.5.2.2 Neurological Disorders
6.5.2.2.1 Neurological disorders market estimates and forecast, 2018 - 2030 (USD Million)
6.5.2.3 Arthitis
6.5.2.3.1 Arthritis market estimates and forecast, 2018 - 2030 (USD Million)
6.5.2.4 Others
6.5.2.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7 Radiotheranostics Market Segment Analysis, By Region, 2018 - 2030 (USD Million)
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2022 & 2030
7.3 Regional Market Dashboard
7.4 Regional Market Snapshot
7.5 SWOT Analysis
7.5.1 North America
7.5.2 Europe
7.5.3 Asia Pacific
7.5.4 Latin America
7.5.5 Middle East & Africa
7.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
7.6.1 North America
7.6.1.1 North America radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.1.2 U.S.
7.6.1.2.1 Key Country Dynamics
7.6.1.2.2 Competitive Scenario
7.6.1.2.3 Regulatory Framework
7.6.1.2.4 Reimbursement Scenario
7.6.1.2.5 U.S. radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.1.3 Canada
7.6.1.3.1 Key Country Dynamics
7.6.1.3.2 Competitive Scenario
7.6.1.3.3 Regulatory Framework
7.6.1.3.4 Reimbursement Scenario
7.6.1.3.5 Canada radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.2 Europe
7.6.2.1 Europe radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.2.2 UK
7.6.2.2.1 Key Country Dynamics
7.6.2.2.2 Competitive Scenario
7.6.2.2.3 Regulatory Framework
7.6.2.2.4 Reimbursement Scenario
7.6.2.2.5 UK radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.2.3 Germany
7.6.2.3.1 Key Country Dynamics
7.6.2.3.2 Competitive Scenario
7.6.2.3.3 Regulatory Framework
7.6.2.23.4 Reimbursement Scenario
7.6.2.3.5 Germany radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.2.4 Spain
7.6.2.4.1 Key Country Dynamics
7.6.2.4.2 Competitive Scenario
7.6.2.4.3 Regulatory Framework
7.6.2.4.4 Reimbursement Scenario
7.6.2.4.5 Spain radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.2.5 France
7.6.2.5.1 Key Country Dynamics
7.6.2.5.2 Competitive Scenario
7.6.2.5.3 Regulatory Framework
7.6.2.5.4 Reimbursement Scenario
7.6.2.5.5 France radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.2.6 Italy
7.6.2.6.1 Key Country Dynamics
7.6.2.6.2 Competitive Scenario
7.6.2.6.3 Regulatory Framework
7.6.2.6.4 Reimbursement Scenario
7.6.2.6.5 Italy radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.2.7 Denmark
7.6.2.7.1 Key Country Dynamics
7.6.2.7.2 Competitive Scenario
7.6.2.7.3 Regulatory Framework
7.6.2.7.4 Reimbursement Scenario
7.6.2.7.5 Denmark radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.2.8 Sweden
7.6.2.8.1 Key Country Dynamics
7.6.2.8.2 Competitive Scenario
7.6.2.8.3 Regulatory Framework
7.6.2.8.4 Reimbursement Scenario
7.6.2.8.5 Sweden radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.2.9 Norway
7.6.2.9.1 Key Country Dynamics
7.6.2.9.2 Competitive Scenario
7.6.2.9.3 Regulatory Framework
7.6.2.9.4 Reimbursement Scenario
7.6.2.9.5 Norway radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.3 Asia Pacific
7.6.3.1 Asia Pacific radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.3.2 Japan
7.6.3.2.1 Key Country Dynamics
7.6.3.2.2 Competitive Scenario
7.6.3.2.3 Regulatory Framework
7.6.3.2.4 Reimbursement Scenario
7.6.3.2.5 Japan radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.3.3 China
7.6.3.3.1 Key Country Dynamics
7.6.3.3.2 Competitive Scenario
7.6.3.3.3 Regulatory Framework
7.6.3.3.4 Reimbursement Scenario
7.6.3.3.5 China radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.3.4 India
7.6.3.4.1 Key Country Dynamics
7.6.3.4.2 Competitive Scenario
7.6.3.4.3 Regulatory Framework
7.6.3.4.4 Reimbursement Scenario
7.6.3.4.5 India radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.3.5 South Korea
7.6.3.5.1 Key Country Dynamics
7.6.3.5.2 Competitive Scenario
7.6.3.5.3 Regulatory Framework
7.6.3.5.4 Reimbursement Scenario
7.6.3.5.5 South Korea radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.3.6 Australia
7.6.3.6.1 Key Country Dynamics
7.6.3.6.2 Competitive Scenario
7.6.3.6.3 Regulatory Framework
7.6.3.6.4 Reimbursement Scenario
7.6.3.6.5 Australia radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.3.7 Thailand
7.6.3.7.1 Key Country Dynamics
7.6.3.7.2 Competitive Scenario
7.6.3.7.3 Regulatory Framework
7.6.3.7.4 Reimbursement Scenario
7.6.3.7.5 Thailand radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.4 Latin America
7.6.4.1 Latin America radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.4.2 Brazil
7.6.4.2.1 Key Country Dynamics
7.6.4.2.2 Competitive Scenario
7.6.4.2.3 Regulatory Framework
7.6.4.2.4 Reimbursement Scenario
7.6.4.2.5 Brazil radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.4.3 Mexico
7.6.4.3.1 Key Country Dynamics
7.6.4.3.2 Competitive Scenario
7.6.4.3.3 Regulatory Framework
7.6.4.3.4 Reimbursement Scenario
7.6.4.3.5 Mexico radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.4.4 Argentina
7.6.4.4.1 Key Country Dynamics
7.6.4.4.2 Competitive Scenario
7.6.4.4.3 Regulatory Framework
7.6.4.4.4 Reimbursement Scenario
7.6.4.4.5 Argentina radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.5 MEA
7.6.5.1 MEA radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.5.2 South Africa
7.6.5.2.1 Key Country Dynamics
7.6.5.2.2 Competitive Scenario
7.6.5.2.3 Regulatory Framework
7.6.5.2.4 Reimbursement Scenario
7.6.5.2.5 South Africa radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.5.3 Saudi Arabia
7.6.5.3.1 Key Country Dynamics
7.6.5.3.2 Competitive Scenario
7.6.5.3.3 Regulatory Framework
7.6.5.3.4 Reimbursement Scenario
7.6.5.3.5 Saudi Arabia radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.5.4 UAE
7.6.5.4.1 Key Country Dynamics
7.6.5.4.2 Competitive Scenario
7.6.5.4.3 Regulatory Framework
7.6.5.4.4 Reimbursement Scenario
7.6.5.4.5 UAE radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
7.6.5.5 Kuwait
7.6.5.5.1 Key Country Dynamics
7.6.5.5.2 Competitive Scenario
7.6.5.5.3 Regulatory Framework
7.6.5.5.4 Reimbursement Scenario
7.6.5.5.5 Kuwait radiotheranostics market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8 Radiotheranostics Market - Competitive Analysis
8.1 Recent Developments & Impact Analysis, by Key Market Participants
8.1.1 Ansoff matrix
8.1.2 Heat map analysis
8.1.3 Major Deals and Strategic Alliances Analysis
8.1.3.1 Joint Ventures
8.1.3.2 Licensing Agreements
8.1.3.3 Product Launches
8.1.3.4 Conferences and Campaigns
8.2 Company Categorization
8.2.1 Innovators
8.2.2 Market Leaders
8.3 Vendor Landscape
8.3.1 List of key distributors and channel partners
8.3.2 Key customers
8.4 Public Companies
8.4.1 Competitive Dashboard Analysis
8.4.1.1 Market Differentiators
8.5 Private Companies
8.5.1 List of key emerging companies
8.6 Company Profiles
8.6.1 Novartis AG
8.6.1.1 Company overview
8.6.1.2 Financial performance
8.6.1.3 Product benchmarking
8.6.1.4 Strategic Initiatives
8.6.2 Progenics Pharmaceuticals, Inc. (Lantheus)
8.6.2.1 Company overview
8.6.2.2 Financial performance
8.6.2.3 Product benchmarking
8.6.2.4 Strategic Initiatives
8.6.3 Telix Pharmaceuticals Limited
8.6.3.1 Company overview
8.6.3.2 Financial performance
8.6.3.3 Product benchmarking
8.6.3.4 Strategic Initiatives
8.6.4 ITM Radiopharma
8.6.4.1 Company overview
8.6.4.2 Financial performance
8.6.4.3 Product benchmarking
8.6.4.4 Strategic Initiatives
8.6.5 Life Molecular Imaging
8.6.5.1 Company overview
8.6.5.2 Financial performance
8.6.5.3 Product benchmarking
8.6.5.4 Strategic Initiatives
8.6.6 RadioMedix
8.6.6.1 Company overview
8.6.6.2 Financial performance
8.6.6.3 Product benchmarking
8.6.6.4 Strategic Initiatives
8.6.7 IsoTherapeutics Group, LLC
8.6.7.1 Company overview
8.6.7.2 Financial performance
8.6.7.3 Product benchmarking
8.6.7.4 Strategic initiatives
8.6.8 Q BioMed Inc
8.6.8.1 Company overview
8.6.8.2 Financial performance
8.6.8.3 Product benchmarking
8.6.8.4 Strategic initiatives
8.6.9 Nordic Nanovector ASA
8.6.9.1 Company overview
8.6.9.2 Financial performance
8.6.9.3 Product benchmarking
8.6.9.4 Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Leading Market Players Anticipated to Witness Highest Growth
Table 4 Global Radiotheranostics Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 6 Global Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 7 Global Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 8 North America Radiotheranostics Market, By Country, 2018 - 2030 (USD Million)
Table 9 North America Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 10 North America Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 11 North America Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 12 U.S. Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 13 U.S. Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 14 U.S. Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 15 Canada Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 16 Canada Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 17 Canada Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 18 Europe Radiotheranostics Market, By Country, 2018 - 2030 (USD Million)
Table 19 Europe Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 20 Europe Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 21 Europe Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 22 UK Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 23 UK Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 24 UK Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 25 Germany Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 26 Germany Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 27 Germany Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 28 France Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 29 France Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 30 France Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 31 Italy Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 32 Italy Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 33 Italy Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 34 Spain Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 35 Spain Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 36 Spain Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 37 Denmark Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 38 Denmark Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 39 Denmark Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 40 Norway Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 41 Norway Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 42 Norway Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 43 Sweden Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 44 Sweden Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 45 Sweden Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Radiotheranostics Market, By Country, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 50 Japan Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 51 Japan Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 52 Japan Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 53 China Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 54 China Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 55 China Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 56 India Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 57 India Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 58 India Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 59 South Korea Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 60 South Korea Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 61 South Korea Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 62 Australia Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 63 Australia Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 64 Australia Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 65 Thailand Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 66 Thailand Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 67 Thailand Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 68 Latin America Radiotheranostics Market, By Country, 2018 - 2030 (USD Million)
Table 69 Latin America Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 70 Latin America Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 71 Latin America Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 72 Brazil Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 73 Brazil Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 74 Brazil Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 75 Argentina Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 76 Argentina Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 77 Argentina Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 78 Mexico Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 79 Mexico Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 80 Mexico Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 81 Middle East and Africa Radiotheranostics Market, By Country, 2018 - 2030 (USD Million)
Table 82 Middle East and Africa Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 83 Middle East and Africa Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 84 Middle East and Africa Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 88 UAE Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 89 UAE Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 90 UAE Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 91 Kuwait Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 92 Kuwait Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 93 Kuwait Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Radiotheranostics market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2022)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Porter’s five forces analysis
Fig. 14 PESTLE analysis
Fig. 15 Radiotheranostics market: Radioisotope movement analysis
Fig. 16 Radiotheranostics market: Radioisotope segment dashboard
Fig. 17 Radiotheranostics market Radioisotope outlook: Key takeaways
Fig. 18 Iodine-131 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Iodine-123 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Gallium-68 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Lutetium-177 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 18F with Y-90 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Radiotheranostics market: Approach movement analysis
Fig. 25 Radiotheranostics market: Approach segment dashboard
Fig. 26 Radiotheranostics market Approach outlook: Key takeaways
Fig. 27 Targeted therapeutic market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Targeted diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Radiotheranostics market: Application movement analysis
Fig. 30 Radiotheranostics market: Application segment dashboard
Fig. 31 Radiotheranostics market: Application outlook: Key takeaways
Fig. 32 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Thyroid cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Neuroendocrine tumors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Hepatocellular carcinoma market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Prostate cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Non-oncology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Neuroendocrine disorders market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Arthritis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Regional outlook, 2022 & 2030
Fig. 43 Regional market dashboard
Fig. 44 Regional market place: Key takeaways
Fig. 45 North America, SWOT
Fig. 46 Europe, SWOT
Fig. 47 Asia Pacific, SWOT
Fig. 48 Latin America, SWOT
Fig. 49 Middle East and Africa, SWOT
Fig. 50 North America
Fig. 51 North America radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 52 U.S.
Fig. 53 U.S. radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 54 Canada
Fig. 55 Canada radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 56 Europe
Fig. 57 Europe radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 58 UK
Fig. 59 UK radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 60 Germany
Fig. 61 Germany radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 62 Spain
Fig. 63 Spain radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 64 France
Fig. 65 France radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 66 Italy
Fig. 67 Italy radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 68 Denmark
Fig. 69 Denmark radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 70 Norway
Fig. 71 Norway radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 72 Sweden
Fig. 73 Sweden radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 74 Asia Pacific
Fig. 75 Asia Pacific radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 76 Japan
Fig. 77 Japan radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 78 China
Fig. 79 China radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 80 India
Fig. 81 India radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 82 South Korea
Fig. 83 South Korea radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 84 Australia
Fig. 85 Australia radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 86 Thailand
Fig. 87 Thailand radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 88 Latin America
Fig. 89 Latin America radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 90 Brazil
Fig. 91 Brazil radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 92 Mexico
Fig. 93 Mexico radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 94 Argentina
Fig. 95 Argentina radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 96 Middle East and Africa
Fig. 97 MEA radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 98 South Africa
Fig. 99 South Africa radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 100 Saudi Arabia
Fig. 101 Saudi Arabia radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 102 UAE
Fig. 103 UAE radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 104 Kuwait
Fig. 105 Kuwait radiotheranostics market, 2018 - 2030 (USD Million)
Fig. 106 Heat map analysis
Fig. 107 Market differentiators

Companies Mentioned

  • Novartis AG
  • Progenics Pharmaceuticals, Inc. (Lantheus)
  • Telix Pharmaceuticals Limited
  • ITM Radiopharma
  • Life Molecular Imaging
  • RadioMedix
  • IsoTherapeutics Group, LLC
  • Q BioMed Inc
  • Nordic Nanovector ASA

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedMay 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 7.51 Billion
Forecasted Market Value ( USD ) by 2030 $ 20.69 Billion
Compound Annual Growth Rate13.4%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Radiotheranostics Global Market Report 2024 - Product Image

Radiotheranostics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Iodine-131 Isotope Market by Application, End User, Form, Therapeutic Procedures, Patient Demographics - Global Forecast 2025-2030 - Product Image

Iodine-131 Isotope Market by Application, End User, Form, Therapeutic Procedures, Patient Demographics - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Germanium-68 Gallium-68 Generators Market by Product Type, Application, End User - Global Forecast 2025-2030 - Product Image

Germanium-68 Gallium-68 Generators Market by Product Type, Application, End User - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Gallium-68 Market Size and Forecast 2020 - 2030, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application, End User, and Geography - Product Image

Gallium-68 Market Size and Forecast 2020 - 2030, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application, End User, and Geography

  • Report
  • 150 Pages
  • Global
From
Iodine-131 (CAS 10043-66-0) Global Market Research Report 2024 - Product Image

Iodine-131 (CAS 10043-66-0) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.